Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies6
  • 7D-1.7%
  • 3M-8.3%
  • 1Y-0.4%
  • YTD3.1%

Over the last 7 days, the Pharma industry has dropped 1.7%, driven by pullbacks from every company within the industry. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are forecast to decline by 16% per annum.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024RM 4.4bRM 2.6bRM 541.3m12.8x8.1x1.7x
Sun, 23 Jun 2024RM 4.5bRM 2.6bRM 541.3m13.2x8.3x1.7x
Tue, 21 May 2024RM 4.6bRM 2.6bRM 556.4m12.3x8.3x1.8x
Thu, 18 Apr 2024RM 4.5bRM 2.6bRM 559.3m12.2x8x1.7x
Sat, 16 Mar 2024RM 4.5bRM 2.6bRM 559.3m12.3x8.1x1.7x
Mon, 12 Feb 2024RM 4.6bRM 2.6bRM 584.9m12.2x7.8x1.8x
Wed, 10 Jan 2024RM 4.4bRM 2.6bRM 584.9m12.5x7.5x1.7x
Fri, 08 Dec 2023RM 4.1bRM 2.6bRM 584.9m12.2x7.1x1.6x
Sun, 05 Nov 2023RM 4.2bRM 2.6bRM 604.4m11.9x6.9x1.6x
Tue, 03 Oct 2023RM 4.3bRM 2.6bRM 604.4m12.5x7.1x1.7x
Thu, 31 Aug 2023RM 4.3bRM 2.6bRM 604.6m12.6x7.1x1.7x
Sat, 29 Jul 2023RM 4.4bRM 2.6bRM 304.7m14.2x14.4x1.7x
Mon, 26 Jun 2023RM 4.3bRM 2.6bRM 304.7m14.6x14.2x1.7x
Wed, 24 May 2023RM 4.8bRM 2.5bRM 291.8m13.5x16.4x1.9x
Fri, 21 Apr 2023RM 4.7bRM 2.5bRM 289.8m13.4x16.4x1.9x
Sun, 19 Mar 2023RM 4.6bRM 2.5bRM 289.8m13.3x15.9x1.8x
Tue, 14 Feb 2023RM 4.6bRM 2.4bRM 270.7m13.2x16.9x1.9x
Thu, 12 Jan 2023RM 4.7bRM 2.4bRM 270.7m12.9x17.5x1.9x
Sat, 10 Dec 2022RM 4.5bRM 2.4bRM 270.7m12.2x16.5x1.8x
Mon, 07 Nov 2022RM 4.1bRM 2.4bRM 249.0m12.3x16.3x1.7x
Wed, 05 Oct 2022RM 3.7bRM 2.4bRM 249.0m11.5x15x1.6x
Fri, 02 Sep 2022RM 3.9bRM 2.4bRM 249.0m11.8x15.5x1.6x
Sun, 31 Jul 2022RM 4.0bRM 2.3bRM 226.0m13.8x17.6x1.7x
Tue, 28 Jun 2022RM 3.5bRM 2.3bRM 226.0m14x15.3x1.5x
Thu, 26 May 2022RM 3.9bRM 2.3bRM 215.3m14.2x18.1x1.7x
Sat, 23 Apr 2022RM 4.0bRM 2.2bRM 204.5m16.6x19.6x1.8x
Mon, 21 Mar 2022RM 3.7bRM 2.2bRM 204.5m16.1x18x1.6x
Wed, 16 Feb 2022RM 3.8bRM 2.1bRM 187.4m16.4x20.2x1.8x
Fri, 14 Jan 2022RM 3.7bRM 2.1bRM 187.4m15.6x19.8x1.7x
Sun, 12 Dec 2021RM 3.7bRM 2.1bRM 187.4m15.3x19.7x1.7x
Tue, 09 Nov 2021RM 3.7bRM 2.0bRM 166.6m20.4x22.2x1.8x
Thu, 07 Oct 2021RM 3.9bRM 2.0bRM 166.6m20.7x23.2x1.9x
Sat, 04 Sep 2021RM 4.2bRM 2.0bRM 166.5m21.3x25.3x2.1x
Mon, 02 Aug 2021RM 4.2bRM 2.0bRM 166.5m19.7x25.2x2.1x
Price to Earnings Ratio

25.2x


Total Market Cap: RM 4.2bTotal Earnings: RM 166.5mTotal Revenue: RM 2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 14.9x202220232024
Current Industry PE
  • Investors are pessimistic on the Malaysian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 8.1x which is lower than its 3-year average PE of 14.9x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 48% per year over the last three years.
  • Revenues for these companies have grown 9.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market-1.65%
Healthcare-1.76%
Pharma-1.69%
Pharma-1.69%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AHEALTH

RM 2.82

Apex Healthcare Berhad

7D

-1.1%

1Y

15.6%

YSPSAH

RM 2.70

Y.S.P. Southeast Asia Holding Berhad

7D

-1.1%

1Y

10.7%

KOTRA

RM 4.09

Kotra Industries Berhad

7D

-2.6%

1Y

-26.0%

DPHARMA

RM 1.21

Duopharma Biotech Berhad

7D

-1.6%

1Y

-6.9%

PLABS

RM 0.23

PeterLabs Holdings Berhad

7D

-4.3%

1Y

21.6%